Status:

UNKNOWN

Community- and mHealth-Based Integrated Management of Diabetes in Primary Healthcare in Rwanda

Lead Sponsor:

University of Aarhus

Collaborating Sponsors:

University of Luxembourg

Karen Elise Jensens Fond

Conditions:

Diabetes Mellitus

Telemedicine

Eligibility:

All Genders

21-80 years

Phase:

NA

Brief Summary

The Home Based Care Practitioners (HBCPs) programme has been established by the Rwandan Ministry of Health in response to the shortage of health professionals. Currently in its pilot first phase, it e...

Detailed Description

Background: In Rwanda, diabetes mellitus (DM) prevalence has been estimated between 3.0 - 3.5%. Several factors, including an increase in screening and diagnosis programmes, the urbanization of the po...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for patients:
  • Adult patients (male and female) aged between 21 and 80 years
  • Diagnosed and confirmed as diabetic patient at least 6 months prior to study start
  • Living in the administrative areas (called "cells") of the district hospitals participating in the first phase of the HBCP programme
  • Residing, and planning to reside within a 2-hour travel distance on foot from the study site for the duration of follow-up
  • Willing and able to adhere to the study protocol
  • Willing and able to give informed consent for enrolment in the study
  • Exclusion Criteria for patients:
  • Severe mental health conditions, including cognitive impairments, as registered in their clinical records
  • Severe hearing and visual impairments as registered in their clinical records
  • Terminal illness
  • Illiteracy
  • Pregnancy or post-partum period
  • Inclusion criteria for HBCPs:
  • Permanent residence in one of the cells of the study
  • Willing and able to give informed consent for enrolment in the study
  • Exclusion criteria for HBCPs:
  • 1\. Not capable of accomplishing questionnaires due to reading or communication problems

Exclusion

    Key Trial Info

    Start Date :

    January 11 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2021

    Estimated Enrollment :

    209 Patients enrolled

    Trial Details

    Trial ID

    NCT03376607

    Start Date

    January 11 2019

    End Date

    December 31 2021

    Last Update

    February 21 2021

    Active Locations (9)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (9 locations)

    1

    Kibuye Referral Hospital

    Kibuye, Karongi, Rwanda

    2

    Ruhengeri Provincial Hospital

    Ruhengeri, Musanze, Rwanda

    3

    Kibungo Referral Hospital

    Kibungo, Ngoma, Rwanda

    4

    Bushenge Provincial Hospital

    Bushenge, Nyamasheke, Rwanda